ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,064.20
      0.91%
      US Tech 100
      17,173.20
      1.85%
      Dow Jones
      38,225.66
      0.85%
      Brent Oil
      83.785
      0.19%
      Bitcoin
      59,417.87
      0.50%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Innovate Biopharmaceuticals Inc (INNT)

      7. Innovate Biopharmaceuticals Inc (INNT) News

      INNT

      Innovate Biopharmaceutic... (INNT)

      Innovate Biopharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:INNT
      DateTimeSourceHeadlineSymbolCompany
      2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
      11/13/20198:00AMPR Newswire (US)RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Dise...NASDAQ:INNTInnovate Biopharmaceuticals Inc
      11/08/20194:14PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      11/07/20194:46PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      10/07/20197:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      08/27/20196:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      08/27/20196:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      08/13/20199:00AMGlobeNewswire Inc.Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac ...NASDAQ:INNTInnovate Biopharmaceuticals Inc
      08/08/20194:43PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      08/08/20194:36PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      08/08/20194:30PMGlobeNewswire Inc.Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate UpdatesNASDAQ:INNTInnovate Biopharmaceuticals Inc
      07/15/20195:30PMGlobeNewswire Inc.Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings ReleaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
      07/15/20196:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      07/03/20195:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      07/03/20195:04PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      07/03/20195:03PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      07/01/20195:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/27/20195:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/24/20197:00AMGlobeNewswire Inc.Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial OfficerNASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/10/20195:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/10/20198:01AMGlobeNewswire Inc.Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac DiseaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/04/20197:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/04/20195:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/04/20195:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      06/03/20198:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      05/31/20195:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      05/31/20194:05PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      05/28/20194:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      05/23/20198:45AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
      05/20/20199:45AMGlobeNewswire Inc.Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Lar...NASDAQ:INNTInnovate Biopharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:INNT